Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi-Aventis Gets Priority Review For Second-Generation Atrial Fib Drug

Aug 11 2008

Related Content

Solvay’s Pulzium Data Does Not Cross The Atlantic: FDA Panel Unanimously Opposes Approval

Dec 12 2007

Sanofi Dronedarone Re-Filing Anticipated In 2008 After FDA “Non Approvable” Letter

Aug 31 2006

Vernakalant, Cardiome Limelight Could Make ARYx Glow

Mar 20 2008

Sanofi-Aventis Heart Drug Multaq Back To FDA In Third Quarter

May 15 2008

ANDROMEDA Strain: Full Data Published From Multaq Trial

Jun 19 2008

Sanofi-Aventis Pares Pipeline, Ditches Antidepressant Amibegron

Aug 11 2008

Astellas/Cardiome’s Kynapid “Approvable”

Aug 11 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window